We are live on ! Find out more
HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $2.92B
1-Year Est. Return 17.65%
This Fund
S&P 500
This Quarter Est. Return
+3.94%
1 Year Est. Return
+17.65%
3 Year Est. Return
+46.66%
5 Year Est. Return
+38.61%
10 Year Est. Return
+120.72%
AUM
$720M
AUM Growth
+$115M
Cap. Flow
+$87.4M
Cap. Flow %
12.13%
Top 10 Hldgs %
49.83%
Holding
741
New
103
Increased
58
Reduced
70
Closed
92

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.48%
2 Financials 7.1%
3 Energy 5.05%
4 Technology 4.9%
5 Healthcare 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNC icon
351
Lincoln National
LNC
$7.81B
$25K ﹤0.01%
490
SCCO icon
352
Southern Copper
SCCO
$143B
$25K ﹤0.01%
899
CHK
353
DELISTED
Chesapeake Energy Corporation
CHK
$25K ﹤0.01%
4
AKZOY
354
DELISTED
Akzo Nobel NV
AKZOY
$25K ﹤0.01%
+999
New +$25K
EWJ icon
355
iShares MSCI Japan ETF
EWJ
$21.7B
$24K ﹤0.01%
500
EWY icon
356
iShares MSCI South Korea ETF
EWY
$23.2B
$24K ﹤0.01%
375
TDC icon
357
Teradata
TDC
$2.6B
$24K ﹤0.01%
600
PNY
358
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$23K ﹤0.01%
620
CAH icon
359
Cardinal Health
CAH
$52.9B
$21K ﹤0.01%
312
CCJ icon
360
Cameco
CCJ
$38.9B
$21K ﹤0.01%
1,060
+1,000
+1,667% +$20.9K
EWZ icon
361
iShares MSCI Brazil ETF
EWZ
$9.16B
$21K ﹤0.01%
425
SBUX icon
362
Starbucks
SBUX
$118B
$21K ﹤0.01%
542
+500
+1,190% +$18.2K
VYX icon
363
NCR Voyix
VYX
$1.05B
$21K ﹤0.01%
978
NBSE
364
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$21K ﹤0.01%
6
XONE
365
DELISTED
The ExOne Company
XONE
$21K ﹤0.01%
+535
New +$16.6K
HRB icon
366
H&R Block
HRB
$5.06B
$20K ﹤0.01%
+592
New +$17.6K
CFN
367
DELISTED
CAREFUSION CORPORATION
CFN
$20K ﹤0.01%
448
IXJ icon
368
iShares Global Healthcare ETF
IXJ
$4.08B
$19K ﹤0.01%
400
TBBK icon
369
The Bancorp
TBBK
$2.74B
$19K ﹤0.01%
1,600
GRA
370
DELISTED
W.R. Grace & Co.
GRA
$19K ﹤0.01%
200
ASB icon
371
Associated Banc-Corp
ASB
$5.72B
$18K ﹤0.01%
1,002
EXPD icon
372
Expeditors International
EXPD
$23B
$18K ﹤0.01%
400
ATVI
373
DELISTED
Activision Blizzard
ATVI
$18K ﹤0.01%
800
-1,200
-60% -$24.7K
REXX
374
DELISTED
Rex Energy Corporation
REXX
$18K ﹤0.01%
100
BRO icon
375
Brown & Brown
BRO
$22.3B
$17K ﹤0.01%
1,104

Similar funds

Hirtle Callaghan & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Hirtle Callaghan & Co held 741 positions worth $720M, up 19% from $605M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Hirtle Callaghan & Co deployed $87.4M of net new capital in Q2 2014, opening 103 new positions and adding to 58 existing holdings. Its largest new stake was Goldman Sachs: 26,355 shares worth $4.41M.

By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 24% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Teledyne Technologies, an estimated $1M trimmed.

  • Hirtle Callaghan & Co's largest Q2 2014 buy was Goldman Sachs: 26,355 shares worth $4.41M.
  • Hirtle Callaghan & Co added most to iShares Russell Mid-Cap ETF in Q2 2014, an estimated $516K increase.
  • Hirtle Callaghan & Co's biggest Q2 2014 reduction was Teledyne Technologies, cutting an estimated $1M.
  • Hirtle Callaghan & Co fully exited iShares MSCI EAFE ETF in Q2 2014, selling an estimated $26M.
  • Hirtle Callaghan & Co's ten largest holdings make up 50% of its $720M portfolio in Q2 2014.
  • Hirtle Callaghan & Co opened 103 new positions and closed 92 in Q2 2014.
  • Hirtle Callaghan & Co's portfolio value rose 19% quarter-over-quarter to $720M.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2014, filed 18 Jul 2014.